Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1995-08-25
1997-11-11
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514552, 514914, A61K 3123
Patent
active
056864884
ABSTRACT:
Compositions and methods treating inflammation are disclosed wherein the compositions contain a pharmaceutically effective anti-inflammatory amount of a polyethoxylated castor oil.
REFERENCES:
patent: 4550022 (1985-10-01), Garabedian et al.
patent: 4829088 (1989-05-01), Doulakas
patent: 4960799 (1990-10-01), Nagy
patent: 4975419 (1990-12-01), Newton et al.
Campbell, W., "Lipid-derived Autacoids: Eicosanoids and Platelet-Activating Factor", Goodman and Gilman's The Pharmacological Basis of Therapeutics, pp. 600-617, Pergman Press, NY (1990).
Nelson, P., "Cyclooxygenase Inhibitors", CRC Handbook of Eicosanoids: Prostaglandins, and Related Lipids, vol. II, Drugs Acting Via the Eicosanoids, pp. 59-133, CRC Press, Boca Raton, FL (1989).
Brems, J., et al., "Effect of Cyclosporine and Steroids on Canine Bile Flow", Hepatolog, 14(3): 523-527 (1991).
Sewell, G., et al., "The Formulation and Stability of A Unit-Dose Oral Vitamin K.sub.1 Preparation", Journal of Clinical Pharmaccy and Therapeutics, 13(1): 73-76 (1988).
Woodburn, K., et al., "Biodistribution and PDT Efficacy of a Ketochlorin Photosensitizer as a Function of the Delivery Vehicle", Journal of Photochemistry and Photobiology, 60(2), 154-159 (1994).
Lodge, N., "Direct Vasoconstrictor Effects of Sandimmune (Cyclosporine A) are Mediated by Its Vehicle Cremophor EL: Inhibition by the Thromboxane A.sub.2 /Prostaglandin Endoperoxide Receptor Antagonist Ifetroban", Journal of Pharmacology and Experimental Therapeutics, 27(2): 730-734 (1994).
Lazarus, J.H., et al., "Polyoxyethylene Castor Oil Derivatives", Handbook of Pharmaceutical Excipients, 10th Edition, pp. 221-224, American Pharmaceutical Association, Washington, D.C. (1986).
Chervinsky, D., et al., "Cremophor-EL Enhances Taxol Efficacy in a Multi-Drug Resistant C1300 Neuroblastoma Cell Line", Anticancer Research 13(1): 93-96 (1993).
Chuang, L., et al., "Cremophor EL Inhibits 12-O-Tetradecanoylphorbol-13-acetate (TPA)-Induced Protein Phosphorylation in Human Myeloblastic Leukemia ML-1 Cells", Anticancer Research 11(4): 1517-1521 (1991).
Furey, et al., Renovascular Effects of Nonprescription Ibuprofen in Elderly Hypertensive Patients with Mild Renal Impairment, Pharmacotherapy, vol. 13, No. 2, pp. 143-148 (1993).
van Delft, Comparison of the Effects of Corticosteroids and Indomethacin on the Response of the Blood-Aqueous Barrier to Injury, Current Eye Research, vol. 6, No. 3, pp. 419-425 (1987).
Bhattacherjee, An Evaluation of Ocular Inflammation Following the Injection of Bacterial Endotoxin into the Rat Food Pad, Investigative Ophthalmology and Visual Science, vol. 24, pp. 196-202 (1983).
Dicorieto, Characterization of the Adhesion of the Human Monocytic Cell Line U937 to Cultured Endothelial Cells, Journal of Clinical Investigation, vol. 75, pp. 1153-1161 (1985).
Goodwin, J., Anti-Inflammatory Drugs, Basic and Clinical Immunology, Eighth Edition, Appleton and Lange, D. Sites (editor), Norwalk, CT, pp. 786-790 (1994).
The United States Pharmacopeia, 22nd Edition; The National Formulary, 17th Edition, pp. 1966-1967 (1990).
Attwood, D., et al., Surfactant Systems Their chemistry, pharmacy and biology, Chapman And Hall, London New York, pp. 323, 337, 444-447, 460-468, and 645-657 (1985).
BASF brochure, "Cremophor EL", pp. 1-7 (1983).
Ash, Michael and Irene, Handbook of Industrial Surfacants, Gower Publishing Company, England, pp. 716-725 (1993).
Inactive Ingrediant Guide, Division of Drug Information Resources, Food and Drug Administration, Center for Drug Evaluation and Research, p. 103 (Oct., 1993).
Gamache Daniel A.
Graff Gustav
Nixon Jon C.
Alcon Laboratories Inc.
Mayo Michael C.
Spivack Phyllis G.
LandOfFree
Polyethoxylated castor oil products as anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyethoxylated castor oil products as anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyethoxylated castor oil products as anti-inflammatory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1229632